Medical News

RSS

Prometheus Laboratories, Bayer Schering Pharma form research collaboration and license agreement

Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced the execution of a research collaboration and license agreement with Bayer Schering Pharma AG, Germany, a worldwide leading specialty pharmaceutical company. The collaboration partners Prometheus' proprietary oncology diagnostic platform with Bayer's broad oncology pipeline in an effort to stratify patients to appropriate drug candidates and potentially accelerate the development of novel oncology therapeutic products.

18 Mar 2010

Medtronic's Advisa DR MRI SureScan pacemaker commercially available in selected European geographies

Medtronic, Inc. announced today the commercial availability of the Advisa DR MRI™ SureScan™ pacemaker in selected European geographies. The Advisa DR MRI SureScan pacemaker is the company’s second-generation pacemaker in a portfolio of devices from Medtronic designed, tested, and approved for use as labeled with MRI machines in selected European geographies.

18 Mar 2010

Expectant mothers’ spatial memory ability reduces during later stages of pregnancy

New research has found that pregnant women's ability to remember the position of objects previously seen is reduced as pregnancy progresses. These findings will be presented this week at the annual Society for Endocrinology BES conference in Manchester.

18 Mar 2010

Patients can partner with their caregivers to prevent health risks and errors

Being hospitalized for acute care presents health risks beyond the medical treatment at hand. Medication errors, patient identification errors, falls and infections are just some of the risks that can be prevented through a closer partnership of patients, their families and medical providers.

18 Mar 2010

Cardima applies for NASDAQ Stock Market listing

Cardima, Inc. today announced that it has applied for the listing of its common stock on the NASDAQ® Stock Market.

18 Mar 2010

Rauland-Borg, Visonic Technologies integrate Elpas RTLS technology with Responder 5 Nurse Call System

Rauland-Borg, the leader in Healthcare Nurse Call Systems and Visonic Technologies a global provider of scalable Active RFID/RTLS based safety, security and management solutions for the healthcare industry announce the integration of Elpas RTLS technology with the Responder 5 Nurse Call System. This joint collaboration between Visonic Technologies and Rauland-Borg provides Responder 5 with real-time staff presence functionality throughout the hospital to room and sub-room level accuracy, automatic visual indication that a patient's needs are being responded to and automatic nurse call cancellation.

18 Mar 2010

Physicians push back on healthcare overhaul

Docs for Patient Care (D4PC), the nation's leading voice of doctors opposing Obamacare and offering better healthcare reform, has produced an ad on the DrudgeReport.com linking to educational videos developed by the organization.

18 Mar 2010

Phytel to receive AMGA Distinguished Corporate Partner Award

The American Medical Group Association announced today that it will present the AMGA Distinguished Corporate Partner Award on March 20 to Phytel, Inc. at its 2010 Annual Conference, March 18-20 at the New Orleans Marriott.

18 Mar 2010

MedeFile International signs revenue-sharing distribution agreement with NSD

MedeFile International, Inc., leader in portable electronic medical records management, announced today the signing of a distribution agreement with one of the country's largest suppliers of auto-related supplemental products, Nation Safe Drivers (NSD), a partnership unparalleled in the field of Personal Health Records(PHR).

18 Mar 2010

New campaign invites people share their journeys through Ontario's health care system

Ontario's doctors are giving a voice to patients across the province with their latest public awareness campaign. The campaign features real people sharing their journeys through Ontario's health care system and highlights the unique relationship between patients and their doctors.

18 Mar 2010

Bone marrow stem cells offer potential treatment for patients with peripheral arterial disease

Bone marrow stem cells suspended in X-ray-visible microbubbles dramatically improve the body's ability to build new blood vessels in the upper leg-providing a potential future treatment for those with peripheral arterial disease or PAD, say researchers at the Society of Interventional Radiology's 35th Annual Scientific Meeting in Tampa, Fla.

18 Mar 2010

Medtronic Arctic Front Cardiac CryoAblation Catheter System: PMA submission for FDA approval complete

Medtronic, Inc. today announced it has completed Pre-Market Approval (PMA) submission in consideration for U.S. Food and Drug Administration (FDA) approval for the Medtronic Arctic Front® Cardiac CryoAblation Catheter System, which is designed for patients with paroxysmal atrial fibrillation (PAF), an irregular quivering of the upper chambers of the heart that starts and stops on its own. Atrial fibrillation (AF) is the most common heart arrhythmia in the United States, with an estimated three million patients suffering from this condition.

18 Mar 2010

Loneliness can raise blood pressure

Chronic feelings of loneliness take a toll on blood pressure over time, causing a marked increase after four years, according to a new study at the University of Chicago.

18 Mar 2010

Standardized skin-care guidelines

Given the complexity of cancer treatment, skin care may seem like a small matter. However, a nurse at the James P. Wilmot Cancer Center knew that skin issues were a constant source of anxiety for many patients receiving radiation therapy, and through research she discovered that routine advice was rooted in myth instead of scientific evidence.

18 Mar 2010

Positive preliminary results from MediciNova's Phase Ib clinical trial of MN-221 for COPD

MediciNova, Inc., a biopharmaceutical company that is publicly traded on the Nasdaq Global Market and the Hercules Market of the Osaka Securities Exchange, today reported positive preliminary results from a Phase Ib clinical trial to evaluate the safety and efficacy of MN-221 in patients with stable, moderate to severe chronic obstructive pulmonary disease (COPD). There were no clinically significant safety concerns noted. Preliminary results demonstrated clinically significant improvements in percent change in forced expiratory volume in one second (FEV(1)).

18 Mar 2010

HRSA survey shows RN workforce is becoming more diverse

The number of licensed registered nurses (RNs) in the United States grew to a new high of 3.1 million between 2004 and 2008 according to a report released today by the Health Resources and Services Administration (HRSA).

18 Mar 2010

Medical Connections Holdings enters into stock purchase agreement with Trustaff Management

Medical Connections Holdings, Inc., one of the nation’s fastest growing healthcare staffing companies specializing in allied health, nurse and physician staffing and recruiting services, said it has entered into a stock purchase agreement to acquire all of the issued and outstanding capital stock of Trustaff Management, Inc., an Ohio corporation and its five wholly-owned limited liability companies.

18 Mar 2010

Cataraqui River contains high levels of mercury contamination

The Inner Harbour on the Cataraqui River in Kingston, Ont., has mercury levels in sediment more than two times the Canadian government's most severe effect limits, according to a Queen's University study.

18 Mar 2010

LSUHSC: Differences in drug metabolism can lead to differences in the effectiveness of candidate drug

Research led by Wayne L. Backes, PhD, Professor of Pharmacology and Associate Dean for Research at LSU Health Sciences Center New Orleans School of Medicine, has found that drug metabolism depends not only upon which enzymes are present in an individual, but also how they interact, and that can be the difference in whether a drug is safely eliminated from the body or is converted into a toxic or carcinogenic byproduct.

18 Mar 2010

Early baldness may not be associated with risk of prostate cancer

Men who start losing their hair at an early age may be less likely to develop prostate cancer in the future, new research suggests.

18 Mar 2010

Medical News

Prometheus Laboratories, Bayer Schering Pharma form research collaboration and license agreement

Medtronic's Advisa DR MRI SureScan pacemaker commercially available in selected European geographies

Expectant mothers’ spatial memory ability reduces during later stages of pregnancy

Patients can partner with their caregivers to prevent health risks and errors

Cardima applies for NASDAQ Stock Market listing

Rauland-Borg, Visonic Technologies integrate Elpas RTLS technology with Responder 5 Nurse Call System

Physicians push back on healthcare overhaul

Phytel to receive AMGA Distinguished Corporate Partner Award

MedeFile International signs revenue-sharing distribution agreement with NSD

New campaign invites people share their journeys through Ontario's health care system

Bone marrow stem cells offer potential treatment for patients with peripheral arterial disease

Medtronic Arctic Front Cardiac CryoAblation Catheter System: PMA submission for FDA approval complete

Loneliness can raise blood pressure

Standardized skin-care guidelines

Positive preliminary results from MediciNova's Phase Ib clinical trial of MN-221 for COPD

HRSA survey shows RN workforce is becoming more diverse

Medical Connections Holdings enters into stock purchase agreement with Trustaff Management

Cataraqui River contains high levels of mercury contamination

LSUHSC: Differences in drug metabolism can lead to differences in the effectiveness of candidate drug

Early baldness may not be associated with risk of prostate cancer

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News